Novel disubstituted chrysene as a potent agent against colon cancer

被引:9
作者
Banik, Bimal K. [1 ]
Basu, Manas K. [2 ]
Becker, Fredrick F. [2 ]
机构
[1] Univ Texas Pan Amer, Dept Chem, Edinburg, TX 78539 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Unit 951, Houston, TX 77030 USA
关键词
chrysene derivative; colon cancer cell line; in vivo test; POLYCYCLIC AROMATIC-COMPOUNDS; ANTICANCER AGENTS; ANTITUMOR-ACTIVITY; DERIVATIVES;
D O I
10.3892/ol.2010.167
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Research on polycyclic aromatic hydrocarbons and their derivatives has received significant attention from the scientific community. The present study involved the synthesis of several novel 6,12-disubstituted chrysene derivatives. Nitration of chrysene with nitric acid produced 6,12-dinitrochrysene which when reduced yielded 6,12-diaminochrysene. A coupling reaction of 6,12-diaminochrysene with an acid in the presence of isobutylchloroformate produced amide. The reduction of amide produced an amine. The amino was converted to a hydrochloride salt. The new compounds were characterized through different types of analytical data. One of these compounds demonstrated marked activity in vivo against a colon cancer cell line. Inhibition of the growth of this tumor was best noted at day 20 when each treatment regimen inhibited the average tumor volume by 50%. In a number of in vivo tests in various regimens, the hydrochloride salt demonstrated consistent inhibition of the growth of the cancer HT-29 cell line. Despite the research progress in polycyclic aromatic compounds, the use of these types of molecules as anticancer agents has not been reported systematically.
引用
收藏
页码:1033 / 1035
页数:3
相关论文
共 12 条
[1]
2-[(ARYLMETHYL)AMINO]-2-METHYL-1,3-PROPANEDIOL DNA INTERCALATORS - AN EXAMINATION OF THE EFFECTS OF AROMATIC RING VARIATION ON ANTITUMOR-ACTIVITY AND DNA-BINDING [J].
BAIR, KW ;
ANDREWS, CW ;
TUTTLE, RL ;
KNICK, VC ;
CORY, M ;
MCKEE, DD .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (07) :1983-1990
[2]
Banik B.K., 2005, ORG SYN, V81, P188
[3]
Polycyclic aromatic compounds as anticancer agents: Structure-activity relationships of chrysene and pyrene derivatives [J].
Banik, BK ;
Becker, FF .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (03) :593-605
[4]
Stereoselective synthesis of β-lactams with polyaromatic imines:: Entry to new and novel anticancer agents [J].
Banik, I ;
Becker, FF ;
Banik, BK .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (01) :12-15
[5]
Polycyclic aromatic compounds as anticancer agents: Synthesis and biological evaluation of dibenzofluorene derivatives [J].
Becker, FF ;
Mukhopadhyay, C ;
Hackfeld, L ;
Banik, I ;
Banik, BK .
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (12) :2693-2699
[6]
POTENTIAL ANTITUMOR AGENTS .59. STRUCTURE-ACTIVITY-RELATIONSHIPS FOR 2-PHENYLBENZIMIDAZOLE-4-CARBOXAMIDES, A NEW CLASS OF MINIMAL DNA-INTERCALATING AGENTS WHICH MAY NOT ACT VIA TOPOISOMERASE-II [J].
DENNY, WA ;
REWCASTLE, GW ;
BAGULEY, BC .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (02) :814-819
[7]
Fukushima T, 1996, ONCOL RES, V8, P95
[8]
Samarium-induced alkyl halide mediated reductive coupling of ketones [J].
Ghatak, A ;
Becker, FF ;
Banik, BK .
TETRAHEDRON LETTERS, 2000, 41 (20) :3793-3796
[9]
Harvey R. G., 1997, POLYCYCLIC AROMATIC
[10]
EVALUATION OF AMONAFIDE IN CERVICAL-CANCER, PHASE-II - A SWOG STUDY [J].
MALVIYA, VK ;
LIU, PY ;
ALBERTS, DS ;
SURWIT, EA ;
CRAIG, JB ;
HANNIGAN, EV .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (01) :41-44